Menu Back toLS07: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model? DCT & Remote Utilization (Part 2)

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS07: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model? DCT & Remote Utilization (Part 2)

Session Chair(s)

Hiroshi  Matsuzawa, MSc

Hiroshi Matsuzawa, MSc

  • Clinical Development
  • Astellas Pharma Inc., Japan
Toshiharu  Sano, RPh

Toshiharu Sano, RPh

  • Executive Director, Japan Development
  • MSD K.K., Japan

Contact us